Welcome to our dedicated page for Healthstream SEC filings (Ticker: HSTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HealthStream filings document the regulatory record for a Tennessee healthcare technology company listed on Nasdaq under HSTM. Its 8-K filings report quarterly and annual operating results, Regulation FD disclosures, dividend declarations, share repurchase programs, acquisitions and amendments to its revolving credit agreement.
The company’s proxy materials cover board matters, executive compensation, equity awards and shareholder voting items under its governance framework and incentive plans. Material-event filings also document executive appointments and related compensatory arrangements, while exhibits to current reports provide formal press releases and agreement summaries tied to HealthStream’s capital allocation, financing and workforce-technology operations.
HealthStream Inc Executive Vice President Trisha L. Coady reported multiple equity transactions tied to restricted share units (RSUs). On February 27, 2026, she acquired 2,000 and 1,803 RSUs through exercises/conversions, which resulted in 3,803 shares of common stock being added to her direct holdings.
As part of the same event, 1,128 common shares were disposed of at $22.09 per share to cover tax liabilities, leaving her with 35,205 directly held common shares. Footnotes explain that each RSU converts into one share upon vesting and that vesting depends on continued service and performance criteria that were achieved for the 2025 performance period, triggering the relevant vesting tranches.
HealthStream Executive Vice President Michael Manning Collier reported equity award activity tied to restricted share units that vested based on performance. On February 27, 2026, he acquired 3,600 and 1,803 shares through RSU exercises at $0.00 per share, and 5,403 shares of common stock reflecting these conversions. To cover tax obligations, 1,602 shares of common stock were withheld at $22.09 per share. After these transactions, Collier directly owned 54,782 shares of HealthStream common stock. Footnotes explain that the RSUs vest over multiple years, contingent on continued service and achievement of annually established performance criteria, with performance goals for the 2025 period having been met.
HealthStream Inc.'s Chief Technology Officer Jeff Cunningham reported equity-related transactions tied to restricted share unit (RSU) vesting. He acquired 2,000 and 541 RSUs that converted into 2,541 shares of common stock, then 754 shares were withheld at $22.09 per share to cover tax liabilities, leaving 33,276 shares held directly.
HealthStream Inc. senior vice president Michael Scott McQuigg reported multiple equity transactions involving restricted share units (RSUs) and common stock. On February 27, 2026, he acquired 2,000 and 541 shares of common stock through the vesting and conversion of RSUs, reflecting previously granted performance-based awards.
He also acquired 2,541 shares of common stock in connection with these RSU conversions, bringing his direct common stock holdings to 31,708 shares before a tax-related share disposition. In a separate transaction coded "F", 754 shares were surrendered at $22.09 per share to cover tax liabilities, reducing his direct holdings to 30,954 shares.
The footnotes explain that each RSU represents a right to receive one share of common stock upon vesting, and that vesting is contingent on continued service and achievement of annual performance criteria. The criteria for performance periods ending December 31, 2025 were achieved, triggering partial vesting of these RSU awards on February 23, 2026 and February 27, 2026.
HealthStream Inc. Executive Vice President Kevin P. O’Hara reported RSU vesting and related tax withholding transactions. On February 27, 2026, he acquired 4,718 shares of common stock at $0.00 per share through the exercise and conversion of restricted share units as they vested.
Footnotes state these shares were acquired upon vesting of RSUs, each representing one share of common stock. A separate transaction disposed of 1,399 shares of common stock at $22.09 per share to satisfy tax liabilities due on the vesting. Additional footnotes describe multi-year performance-based vesting schedules, with performance criteria for the January 1, 2025 through December 31, 2025 period achieved, triggering a portion of the RSU vesting on the February 2026 dates.
HealthStream Inc. CFO and SVP Scott Alexander Roberts reported RSU vesting and related share movements. On February 27, 2026, he acquired 2,000 and 541 shares through the exercise or conversion of restricted share units, and 2,541 common shares were delivered from these awards.
To cover tax obligations, 754 common shares were withheld at a price of $22.09 per share in a tax-withholding disposition, rather than an open-market sale. After these transactions, he directly owned 32,563 shares of common stock.
HealthStream, Inc. provides SaaS-based workforce, learning, credentialing, and scheduling solutions for healthcare organizations, professionals, and students, built around its hStream technology platform and hStream ID. The company highlights growing use of AI and machine learning across its applications and positions hStream as a single, interoperable platform for healthcare workforce tools.
HealthStream operates in a large, fragmented healthcare training and credentialing market and faces competition from broad HCM vendors and healthcare-focused specialists. It reports 1,139 full-time and 21 part-time employees and continued use of acquisitions, such as Virsys12 and MissionCare in 2025, to expand its ecosystem. Risk factors emphasize macroeconomic and healthcare funding pressures, evolving AI regulation, talent competition, integration and investment risks, and sensitivity to customer renewals in a predominantly subscription-based revenue model.
HealthStream, Inc. reported record fourth quarter 2025 revenue of $79.7 million, up 7.4% from 2024, but lower GAAP profits due mainly to a one-time $3.8 million CEO Stock Gift charge. Excluding this item, non-GAAP operating income rose to $6.2 million and non-GAAP EPS to $0.18 per diluted share.
For full-year 2025, revenue grew 4.3% to $304.1 million, with adjusted EBITDA up 7.5% to $71.8 million. The company ended the year with $57.0 million in cash, cash equivalents, and marketable securities, and repurchased 1,111,590 shares for $30.0 million.
HealthStream completed acquisitions of Virsys12 and MissionCare Collective and increased its quarterly dividend to $0.035 per share, payable March 20, 2026. For 2026, it guides to revenue of $323.0–$330.0 million, net income of $20.4–$22.8 million, and adjusted EBITDA of $73.0–$77.0 million.
LoPresto Jennifer Hayes, a Senior Vice President of the issuer of HSTM, has filed an initial statement of beneficial ownership. She directly holds 6,056 shares of common stock. She also holds multiple blocks of restricted share units (RSUs), each representing the right to receive one common share upon vesting, with vesting dates from March 23, 2026 through December 9, 2029, all contingent on continued service. In addition, she holds an employee stock option for 5,641 shares of common stock at an exercise price of $23.93, expiring on December 9, 2035, also subject to a four-year vesting schedule tied to continued service.
The Vanguard Group has filed an amended Schedule 13G showing a significant ownership position in HealthStream Inc. As of 12/31/2025, Vanguard reports beneficial ownership of 2,536,901 shares of HealthStream common stock, representing 8.55% of the outstanding class.
Vanguard reports shared voting power over 184,222 shares and shared dispositive power over all 2,536,901 shares, with no sole voting or dispositive power. Vanguard states the shares are held in the ordinary course of business, not for the purpose of changing or influencing control of HealthStream. The filing also notes an internal realignment on January 12, 2026, after which certain Vanguard subsidiaries may report beneficial ownership separately.